Immediate Impact
60 standout
Citing Papers
Chemically Modified Platforms for Better RNA Therapeutics
2024 Standout
Sacituzumab Govitecan in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer
2022 Standout
Works of Gralla Rj being referenced
Methodology in anti-emetic trials.
1991
Consecutive dose-finding trials adding lorazepam to the combination of metoclopramide plus dexamethasone: improved subjective effectiveness over the combination of diphenhydramine plus metoclopramide plus dexamethasone.
1985
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Gralla Rj | 210 | 94 | 135 | 148 | 30 | 424 | |
| Sanambar Sadighi | 147 | 72 | 163 | 136 | 50 | 458 | |
| Dimitrios Papanikolaou | 91 | 92 | 146 | 73 | 26 | 425 | |
| Jianhong Zhu | 127 | 82 | 80 | 164 | 38 | 509 | |
| Chiara Angeletti | 134 | 130 | 78 | 195 | 35 | 496 | |
| Hanlim Moon | 90 | 74 | 139 | 102 | 31 | 427 | |
| Deniz Yüce | 128 | 47 | 72 | 141 | 32 | 434 | |
| Colleen Gilbert | 158 | 69 | 53 | 83 | 21 | 416 | |
| Amandine Gouverneur | 113 | 107 | 57 | 55 | 28 | 396 | |
| M Hahn | 181 | 36 | 211 | 180 | 27 | 442 | |
| Tamer Çolakoğlu | 86 | 75 | 156 | 122 | 35 | 397 |
All Works
Loading papers...